TGFB2 (transforming growth factor beta 2)
|
Gene
|
Entrez ID
Entrez Gene ID - the GENE ID in NCBI Gene database.
|
7042 |
Gene nameGene Name - the full gene name approved by the HGNC.
|
Transforming growth factor beta 2 |
Gene symbolGene Symbol - the official gene symbol approved by the HGNC, which is a short abbreviated form of the gene name.
|
TGFB2 |
SynonymsGene synonyms aliases
|
G-TSF, LDS4, TGF-beta2 |
ChromosomeChromosome number
|
1 |
Chromosome locationChromosomal Location - indicates the cytogenetic location of the gene or region on the chromosome.
|
1q41 |
SummarySummary of gene provided in NCBI Entrez Gene.
|
This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate a latency-associated peptide (LAP) and a mature peptide, and is found in either a latent form composed of a mature peptide homodimer, a LAP homodimer, and a latent TGF-beta binding protein, or in an active form consisting solely of the mature peptide homodimer. The mature peptide may also form heterodimers with other TGF-beta family members. Disruption of the TGF-beta/SMAD pathway has been implicated in a variety of human cancers. A chromosomal translocation that includes this gene is associated with Peters` anomaly, a congenital defect of the anterior chamber of the eye. Mutations in this gene may be associated with Loeys-Dietz syndrome. This gene encodes multiple isoforms that may undergo similar proteolytic processing. [provided by RefSeq, Aug 2016] |
SNPsSNP information provided by dbSNP.
|
SNP ID |
Visualize variation |
Clinical significance |
Consequence |
rs10482810 |
G>C |
Conflicting-interpretations-of-pathogenicity, benign-likely-benign, likely-benign |
Non coding transcript variant, missense variant, coding sequence variant |
rs11466408 |
C>T |
Conflicting-interpretations-of-pathogenicity, likely-benign |
Intron variant |
rs387907278 |
C>A |
Pathogenic |
Coding sequence variant, missense variant, non coding transcript variant |
rs398122884 |
ACAAT>- |
Pathogenic |
Coding sequence variant, frameshift variant, non coding transcript variant |
rs398122885 |
C>A,T |
Pathogenic |
Synonymous variant, coding sequence variant, stop gained, non coding transcript variant |
rs730880221 |
C>T |
Likely-pathogenic |
Stop gained, coding sequence variant, non coding transcript variant |
rs863223790 |
G>T |
Pathogenic |
Coding sequence variant, stop gained, non coding transcript variant |
rs863223792 |
C>T |
Pathogenic, likely-pathogenic |
Missense variant, coding sequence variant, non coding transcript variant |
rs863223793 |
G>T |
Likely-pathogenic |
Missense variant, coding sequence variant, non coding transcript variant |
rs863223795 |
->T |
Likely-pathogenic |
Coding sequence variant, frameshift variant, non coding transcript variant |
rs863223796 |
A>-,AA |
Pathogenic-likely-pathogenic, pathogenic |
Coding sequence variant, intron variant, frameshift variant |
rs863223797 |
C>- |
Pathogenic |
Coding sequence variant, frameshift variant, non coding transcript variant |
rs869025531 |
C>T |
Pathogenic, likely-pathogenic |
Coding sequence variant, stop gained, non coding transcript variant |
rs869025533 |
->A |
Likely-pathogenic |
Coding sequence variant, frameshift variant, non coding transcript variant |
rs869312903 |
C>A,T |
Pathogenic-likely-pathogenic, likely-pathogenic, uncertain-significance |
Missense variant, coding sequence variant, non coding transcript variant |
rs1057518029 |
A>G |
Likely-pathogenic |
Splice acceptor variant |
rs1057518597 |
A>- |
Likely-pathogenic |
Frameshift variant, coding sequence variant, non coding transcript variant |
rs1057518684 |
G>A |
Likely-pathogenic |
Missense variant, coding sequence variant, non coding transcript variant |
rs1057521150 |
G>A |
Likely-pathogenic, pathogenic |
Missense variant, coding sequence variant, non coding transcript variant |
rs1064793278 |
G>A |
Likely-pathogenic |
Missense variant, coding sequence variant, non coding transcript variant |
rs1064796256 |
AA>- |
Likely-pathogenic, pathogenic |
Frameshift variant, coding sequence variant, non coding transcript variant |
rs1436552875 |
C>T |
Likely-pathogenic |
Coding sequence variant, non coding transcript variant, missense variant |
rs1553303161 |
TCAA>G |
Likely-pathogenic |
Intron variant, splice acceptor variant |
rs1553303203 |
CGGCGGAAGA>- |
Pathogenic |
Non coding transcript variant, frameshift variant, coding sequence variant |
rs1553303213 |
G>A |
Not-provided, likely-pathogenic, uncertain-significance |
Non coding transcript variant, coding sequence variant, missense variant |
rs1553303221 |
G>A |
Pathogenic |
Splice donor variant |
rs1553303352 |
C>T |
Likely-pathogenic |
Non coding transcript variant, coding sequence variant, missense variant |
rs1553303357 |
C>A |
Pathogenic |
Non coding transcript variant, coding sequence variant, stop gained |
rs1571902862 |
TATAAAGT>A |
Pathogenic |
Coding sequence variant, intron variant, frameshift variant |
rs1571904218 |
->A |
Pathogenic |
Coding sequence variant, non coding transcript variant, frameshift variant |
rs1571904338 |
G>A |
Likely-pathogenic |
Splice donor variant |
|
miRNAmiRNA information provided by mirtarbase database.
|
miRTarBase ID |
miRNA |
Experiments |
Reference |
MIRT002285 |
hsa-miR-141-3p |
Immunoblot, Luciferase reporter assay, qRT-PCR |
18483486 |
MIRT002285 |
hsa-miR-141-3p |
Flow, Luciferase reporter assay, qRT-PCR, Western blot |
28115163 |
MIRT006058 |
hsa-miR-29b-3p |
ELISA, GFP reporter assay, qRT-PCR |
21273536 |
MIRT006058 |
hsa-miR-29b-3p |
Luciferase reporter assay, qRT-PCR |
23354167 |
MIRT017363 |
hsa-miR-335-5p |
Microarray |
18185580 |
MIRT019708 |
hsa-miR-375 |
Microarray |
20215506 |
MIRT030844 |
hsa-miR-21-5p |
Microarray |
18591254 |
MIRT030844 |
hsa-miR-21-5p |
Luciferase reporter assay |
27388239 |
MIRT437425 |
hsa-miR-137 |
Luciferase reporter assay, qRT-PCR, Western blot |
24465609 |
MIRT652723 |
hsa-miR-4446-5p |
HITS-CLIP |
23824327 |
MIRT652724 |
hsa-miR-510-3p |
HITS-CLIP |
23824327 |
MIRT652725 |
hsa-miR-3679-3p |
HITS-CLIP |
23824327 |
MIRT652726 |
hsa-miR-8058 |
HITS-CLIP |
23824327 |
MIRT652727 |
hsa-miR-5009-5p |
HITS-CLIP |
23824327 |
MIRT652728 |
hsa-miR-6826-3p |
HITS-CLIP |
23824327 |
MIRT652729 |
hsa-miR-631 |
HITS-CLIP |
23824327 |
MIRT652730 |
hsa-miR-3661 |
HITS-CLIP |
23824327 |
MIRT652731 |
hsa-miR-422a |
HITS-CLIP |
23824327 |
MIRT652732 |
hsa-miR-378i |
HITS-CLIP |
23824327 |
MIRT652733 |
hsa-miR-378h |
HITS-CLIP |
23824327 |
MIRT652734 |
hsa-miR-378f |
HITS-CLIP |
23824327 |
MIRT652735 |
hsa-miR-378e |
HITS-CLIP |
23824327 |
MIRT652736 |
hsa-miR-378d |
HITS-CLIP |
23824327 |
MIRT652737 |
hsa-miR-378c |
HITS-CLIP |
23824327 |
MIRT652738 |
hsa-miR-378b |
HITS-CLIP |
23824327 |
MIRT652739 |
hsa-miR-378a-3p |
HITS-CLIP |
23824327 |
MIRT652739 |
hsa-miR-378a-3p |
Flow, Luciferase reporter assay, qRT-PCR, Western blot |
27855367 |
MIRT652740 |
hsa-miR-3690 |
HITS-CLIP |
23824327 |
MIRT652741 |
hsa-miR-6832-3p |
HITS-CLIP |
23824327 |
MIRT652742 |
hsa-miR-619-3p |
HITS-CLIP |
23824327 |
MIRT731238 |
hsa-miR-193a-3p |
Luciferase reporter assay |
26822621 |
MIRT732234 |
hsa-miR-200a-3p |
Luciferase reporter assay, qRT-PCR, Western blot |
27267902 |
MIRT732715 |
hsa-miR-199a-5p |
Luciferase reporter assay, qRT-PCR |
27842518 |
MIRT733135 |
hsa-miR-148a-3p |
Flow, Immunofluorescence, Luciferase reporter assay, qRT-PCR, Western blot |
26983401 |
MIRT734688 |
hsa-miR-142-5p |
Western blot |
25586666 |
MIRT735093 |
hsa-miR-23a-5p |
Luciferase reporter assay |
27388239 |
MIRT735094 |
hsa-miR-23b-5p |
Luciferase reporter assay |
27388239 |
MIRT735095 |
hsa-miR-145-5p |
Luciferase reporter assay |
27388239 |
MIRT735113 |
hsa-miR-153-5p |
Luciferase reporter assay, qRT-PCR, Western blot |
25793604 |
|
Transcription factors
|
|
Gene ontology (GO)Gene ontology information of associated ontologies with gene provided by GO database.
|
GO ID |
Ontology |
Definition |
Evidence |
Reference |
GO:0000902 |
Process |
Cell morphogenesis |
IDA |
15896309 |
GO:0001501 |
Process |
Skeletal system development |
ISS |
|
GO:0001540 |
Function |
Amyloid-beta binding |
IDA |
16227582 |
GO:0001654 |
Process |
Eye development |
IDA |
15944186 |
GO:0001666 |
Process |
Response to hypoxia |
IMP |
12411310 |
GO:0001822 |
Process |
Kidney development |
ISS |
|
GO:0001837 |
Process |
Epithelial to mesenchymal transition |
IDA |
10092230, 18223299 |
GO:0001837 |
Process |
Epithelial to mesenchymal transition |
TAS |
14679171 |
GO:0001843 |
Process |
Neural tube closure |
ISS |
|
GO:0001942 |
Process |
Hair follicle development |
IDA |
10433821 |
GO:0001942 |
Process |
Hair follicle development |
ISS |
|
GO:0002576 |
Process |
Platelet degranulation |
TAS |
|
GO:0003007 |
Process |
Heart morphogenesis |
IDA |
10092230 |
GO:0003148 |
Process |
Outflow tract septum morphogenesis |
ISS |
|
GO:0003149 |
Process |
Membranous septum morphogenesis |
ISS |
|
GO:0003179 |
Process |
Heart valve morphogenesis |
ISS |
|
GO:0003181 |
Process |
Atrioventricular valve morphogenesis |
ISS |
|
GO:0003184 |
Process |
Pulmonary valve morphogenesis |
ISS |
|
GO:0003203 |
Process |
Endocardial cushion morphogenesis |
ISS |
|
GO:0003215 |
Process |
Cardiac right ventricle morphogenesis |
ISS |
|
GO:0003222 |
Process |
Ventricular trabecula myocardium morphogenesis |
ISS |
|
GO:0003274 |
Process |
Endocardial cushion fusion |
ISS |
|
GO:0003289 |
Process |
Atrial septum primum morphogenesis |
ISS |
|
GO:0003407 |
Process |
Neural retina development |
ISS |
|
GO:0005102 |
Function |
Signaling receptor binding |
IMP |
16227582 |
GO:0005114 |
Function |
Type II transforming growth factor beta receptor binding |
IBA |
21873635 |
GO:0005114 |
Function |
Type II transforming growth factor beta receptor binding |
IDA |
11157754 |
GO:0005114 |
Function |
Type II transforming growth factor beta receptor binding |
IMP |
8167376 |
GO:0005114 |
Function |
Type II transforming growth factor beta receptor binding |
IPI |
1333888, 7852346, 11157754 |
GO:0005125 |
Function |
Cytokine activity |
IBA |
21873635 |
GO:0005160 |
Function |
Transforming growth factor beta receptor binding |
IDA |
10092230, 16227582 |
GO:0005515 |
Function |
Protein binding |
IPI |
2022183, 2119582, 8617200, 10930463, 11157754, 16227582, 17827158, 19651619, 25241761, 32814053 |
GO:0005576 |
Component |
Extracellular region |
IDA |
16227582 |
GO:0005576 |
Component |
Extracellular region |
TAS |
2119582 |
GO:0005615 |
Component |
Extracellular space |
IBA |
21873635 |
GO:0005615 |
Component |
Extracellular space |
IDA |
24263861 |
GO:0006468 |
Process |
Protein phosphorylation |
IDA |
18358889 |
GO:0007050 |
Process |
Cell cycle arrest |
IDA |
18223299 |
GO:0007179 |
Process |
Transforming growth factor beta receptor signaling pathway |
IBA |
21873635 |
GO:0007179 |
Process |
Transforming growth factor beta receptor signaling pathway |
IDA |
11157754, 18358889 |
GO:0007435 |
Process |
Salivary gland morphogenesis |
IEP |
18080134 |
GO:0007507 |
Process |
Heart development |
IDA |
15896309 |
GO:0008083 |
Function |
Growth factor activity |
IEA |
|
GO:0008219 |
Process |
Cell death |
IDA |
16227582 |
GO:0008284 |
Process |
Positive regulation of cell population proliferation |
IDA |
15896309 |
GO:0008285 |
Process |
Negative regulation of cell population proliferation |
IDA |
15944186 |
GO:0008347 |
Process |
Glial cell migration |
IDA |
18431253 |
GO:0008584 |
Process |
Male gonad development |
ISS |
|
GO:0009611 |
Process |
Response to wounding |
IEP |
16891397, 18040277 |
GO:0009792 |
Process |
Embryo development ending in birth or egg hatching |
TAS |
2119582 |
GO:0010002 |
Process |
Cardioblast differentiation |
IDA |
15896309 |
GO:0010629 |
Process |
Negative regulation of gene expression |
IDA |
25217442 |
GO:0010634 |
Process |
Positive regulation of epithelial cell migration |
IDA |
17960115 |
GO:0010693 |
Process |
Negative regulation of alkaline phosphatase activity |
IDA |
18358889 |
GO:0010718 |
Process |
Positive regulation of epithelial to mesenchymal transition |
IDA |
17999987, 18505915 |
GO:0010862 |
Process |
Positive regulation of pathway-restricted SMAD protein phosphorylation |
IBA |
21873635 |
GO:0010936 |
Process |
Negative regulation of macrophage cytokine production |
IDA |
20875417 |
GO:0014068 |
Process |
Positive regulation of phosphatidylinositol 3-kinase signaling |
IDA |
18223299 |
GO:0016477 |
Process |
Cell migration |
IDA |
10092230 |
GO:0016525 |
Process |
Negative regulation of angiogenesis |
IDA |
25217442, 28977001 |
GO:0030097 |
Process |
Hemopoiesis |
ISS |
|
GO:0030199 |
Process |
Collagen fibril organization |
IDA |
16891397 |
GO:0030307 |
Process |
Positive regulation of cell growth |
IDA |
15896309, 20573232 |
GO:0030308 |
Process |
Negative regulation of cell growth |
IDA |
18358889 |
GO:0030326 |
Process |
Embryonic limb morphogenesis |
ISS |
|
GO:0030424 |
Component |
Axon |
ISS |
|
GO:0030509 |
Process |
BMP signaling pathway |
IBA |
21873635 |
GO:0030593 |
Process |
Neutrophil chemotaxis |
ISS |
|
GO:0031069 |
Process |
Hair follicle morphogenesis |
ISS |
|
GO:0031093 |
Component |
Platelet alpha granule lumen |
TAS |
|
GO:0032147 |
Process |
Activation of protein kinase activity |
IDA |
17192487, 17960115 |
GO:0032570 |
Process |
Response to progesterone |
IDA |
18039789 |
GO:0032874 |
Process |
Positive regulation of stress-activated MAPK cascade |
IDA |
17192487 |
GO:0032909 |
Process |
Regulation of transforming growth factor beta2 production |
IMP |
12411310 |
GO:0033630 |
Process |
Positive regulation of cell adhesion mediated by integrin |
IDA |
17960115, 18223299 |
GO:0034714 |
Function |
Type III transforming growth factor beta receptor binding |
IBA |
21873635 |
GO:0034714 |
Function |
Type III transforming growth factor beta receptor binding |
IMP |
8167376 |
GO:0034714 |
Function |
Type III transforming growth factor beta receptor binding |
IPI |
7852346, 11157754 |
GO:0035910 |
Process |
Ascending aorta morphogenesis |
ISS |
|
GO:0042060 |
Process |
Wound healing |
ISS |
|
GO:0042127 |
Process |
Regulation of cell population proliferation |
IBA |
21873635 |
GO:0042416 |
Process |
Dopamine biosynthetic process |
ISS |
|
GO:0042476 |
Process |
Odontogenesis |
NAS |
18078367 |
GO:0042493 |
Process |
Response to drug |
IDA |
20573232 |
GO:0042704 |
Process |
Uterine wall breakdown |
TAS |
18039789 |
GO:0042803 |
Function |
Protein homodimerization activity |
IDA |
2119582 |
GO:0043025 |
Component |
Neuronal cell body |
ISS |
|
GO:0043525 |
Process |
Positive regulation of neuron apoptotic process |
IDA |
16227582 |
GO:0045216 |
Process |
Cell-cell junction organization |
IDA |
18505915 |
GO:0045726 |
Process |
Positive regulation of integrin biosynthetic process |
IDA |
17960115 |
GO:0045747 |
Process |
Positive regulation of Notch signaling pathway |
IDA |
25217442 |
GO:0045778 |
Process |
Positive regulation of ossification |
IEP |
17401695 |
GO:0045787 |
Process |
Positive regulation of cell cycle |
ISS |
|
GO:0045823 |
Process |
Positive regulation of heart contraction |
IDA |
15896309 |
GO:0046580 |
Process |
Negative regulation of Ras protein signal transduction |
ISS |
|
GO:0048103 |
Process |
Somatic stem cell division |
ISS |
|
GO:0048566 |
Process |
Embryonic digestive tract development |
IEP |
20875417 |
GO:0048666 |
Process |
Neuron development |
ISS |
|
GO:0048699 |
Process |
Generation of neurons |
TAS |
15944186 |
GO:0048839 |
Process |
Inner ear development |
ISS |
|
GO:0050680 |
Process |
Negative regulation of epithelial cell proliferation |
IDA |
17217916 |
GO:0050680 |
Process |
Negative regulation of epithelial cell proliferation |
IMP |
16943770 |
GO:0050714 |
Process |
Positive regulation of protein secretion |
IDA |
18505915 |
GO:0050778 |
Process |
Positive regulation of immune response |
ISS |
|
GO:0051781 |
Process |
Positive regulation of cell division |
IEA |
|
GO:0051794 |
Process |
Regulation of timing of catagen |
IDA |
15955085 |
GO:0051795 |
Process |
Positive regulation of timing of catagen |
IDA |
15955085 |
GO:0051891 |
Process |
Positive regulation of cardioblast differentiation |
IDA |
15896309 |
GO:0060038 |
Process |
Cardiac muscle cell proliferation |
IDA |
15896309 |
GO:0060065 |
Process |
Uterus development |
ISS |
|
GO:0060317 |
Process |
Cardiac epithelial to mesenchymal transition |
IDA |
10092230 |
GO:0060389 |
Process |
Pathway-restricted SMAD protein phosphorylation |
IDA |
11157754, 18358889 |
GO:0060395 |
Process |
SMAD protein signal transduction |
IBA |
21873635 |
GO:0060395 |
Process |
SMAD protein signal transduction |
IDA |
17192487 |
GO:0060412 |
Process |
Ventricular septum morphogenesis |
ISS |
|
GO:0060413 |
Process |
Atrial septum morphogenesis |
ISS |
|
GO:0061626 |
Process |
Pharyngeal arch artery morphogenesis |
ISS |
|
GO:0062009 |
Process |
Secondary palate development |
ISS |
|
GO:0062023 |
Component |
Collagen-containing extracellular matrix |
IDA |
18049952 |
GO:0097191 |
Process |
Extrinsic apoptotic signaling pathway |
IDA |
17217916 |
GO:1902256 |
Process |
Regulation of apoptotic process involved in outflow tract morphogenesis |
ISS |
|
GO:1902895 |
Process |
Positive regulation of pri-miRNA transcription by RNA polymerase II |
IDA |
25217442 |
GO:1903659 |
Process |
Regulation of complement-dependent cytotoxicity |
IMP |
16034134 |
GO:1903701 |
Process |
Substantia propria of cornea development |
ISS |
|
GO:1904888 |
Process |
Cranial skeletal system development |
ISS |
|
GO:1905006 |
Process |
Negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation |
ISS |
|
GO:1905007 |
Process |
Positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation |
ISS |
|
|
Other IDsOther ids provides unique ids of gene in databases such as OMIM, HGNC, ENSEMBLE.
|
|
Protein
|
UniProt ID |
P61812 |
Protein name |
Transforming growth factor beta-2 proprotein (Cetermin) (Glioblastoma-derived T-cell suppressor factor) (G-TSF) [Cleaved into: Latency-associated peptide (LAP); Transforming growth factor beta-2 (TGF-beta-2)] |
Protein function |
Transforming growth factor beta-2 proprotein: Precursor of the Latency-associated peptide (LAP) and Transforming growth factor beta-2 (TGF-beta-2) chains, which constitute the regulatory and active subunit of TGF-beta-2, respectively. ; [Latency-associated peptide]: Required to maintain the Transforming growth factor beta-2 (TGF-beta-2) chain in a latent state during storage in extracellular matrix (By similarity). Associates non-covalently with TGF-beta-2 and regulates its activation via interaction with 'milieu molecules', such as LTBP1 and LRRC32/GARP, that control activation of TGF-beta-2 (By similarity). ; Transforming growth factor beta-2: Multifunctional protein that regulates various processes such as angiogenesis and heart development (PubMed:22772371, PubMed:22772368). Activation into mature form follows different steps: following cleavage of the proprotein in the Golgi apparatus, Latency-associated peptide (LAP) and Transforming growth factor beta-2 (TGF-beta-2) chains remain non-covalently linked rendering TGF-beta-2 inactive during storage in extracellular matrix (By similarity). At the same time, LAP chain interacts with 'milieu molecules', such as LTBP1 and LRRC32/GARP, that control activation of TGF-beta-2 and maintain it in a latent state during storage in extracellular milieus (By similarity). Once activated following release of LAP, TGF-beta-2 acts by binding to TGF-beta receptors (TGFBR1 and TGFBR2), which transduce signal (By similarity). |
PDB |
1TFG
,
2TGI
,
4KXZ
,
5TX4
,
5TY4
,
6I9J
|
Family and domains |
Pfam
Accession |
ID |
Position in sequence |
Description |
Type |
PF00688 |
TGFb_propeptide |
20 → 284 |
TGF-beta propeptide |
Family |
PF00019 |
TGF_beta |
316 → 413 |
Transforming growth factor beta like domain |
Domain |
|
Sequence |
|
Sequence length |
414 |
Interactions |
View interactions |
|
|